Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Nike Industry Stock Comparison

Sell
22

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
16.17
Seasonality Move:
-7.85%
Sell
27

NKE
Nike

Last Price:
76.83
Seasonality Move:
5.79%
Sell
22
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $16.65. The Score for BIS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Nike (NKE) is a Sell

Is Nike a Buy, Sell or Hold?

  • The current Nike [NKE] share price is $75.37. The Score for NKE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NKE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $16.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

NKE Stock Price Chart

What is Nike's stock price today?

  • The Nike share price today is $75.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing selling pressure, which indicates risk of future bearish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 42.77 Sell
Chaikin Money Flow: 2676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.57 - 17.77) Sell
Bollinger Bands (100): (16.95 - 19.09) Sell

NKE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.17 Sell
Relative Strength Index (14 RSI): 18.26 Sell
Chaikin Money Flow: -81897721 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.64 - 97.74) Sell
Bollinger Bands (100): (90.8 - 101.2) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.73 Sell
20-day SMA: 16.96 Sell
50-day SMA: 17.97 Sell
200-day SMA: 19.72 Sell
8-day EMA: 16.66 Sell
20-day EMA: 16.98 Sell
50-day EMA: 17.57 Sell
200-day EMA: 19 Sell

NKE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.1 Sell
50-day SMA: 93.36 Sell
200-day SMA: 100.21 Sell
8-day EMA: 90.62 Sell
20-day EMA: 92.85 Sell
50-day EMA: 93.83 Sell
200-day EMA: 99.73 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nike Earnings Growth & NKE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.48 per share, and a decrease next year of $0.37 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nike Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):